Latest Chronic granulomatous disease Stories
TOWSON, Md., Feb.
Scientists at Emory University School of Medicine have identified a new type of anti-inflammatory compound that may be useful in treating a wide range of conditions, including neurodegenerative and autoimmune diseases.
University of Cincinnati (UC) researchers have found that an imbalance in the regulation of certain T cells—the cells in the body that fight off infection or attack the system in certain autoimmune diseases—may put certain people at a higher risk of having recurrent cases of Clostridium difficile, or C. Diff, infection.
Sometimes our immune defence attacks our own cells.
Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC), among others, have identified an important cog in the molecular machinery of plant immunity - a discovery that could help crop breeders produce disease-resistant varieties to help ensure future food security.
Investigators at the National Institutes of Health have observed that the survival rate of people with a rare immunodeficiency disease called chronic granulomatous disease (CGD) is greatly improved when even very low levels of microbe-killing molecules are present.
A deficiency in one of the immune system's enzymes affects the severity of autoimmune diseases such as MS, and explains why the course of these diseases can vary so much.
Two genetic mutations that may put individuals at increased risk of fungal infections have been identified by scientists from UCL and Radboud University, increasing understanding about the genetic basis of these infections and potentially aiding the development of new treatments.
New findings related to an uncommon genetic disorder may impact diagnosis and treatment of inflammatory bowel disease.
By Barry Nelson A PIONEERING North-East stem cell unit is carrying outmore lifesaving transplants than ever before, after the Government agreed to increase its funding.
- A political dynamiter.